SCHEMBL28699987

SCHEMBL28699987

CON(Nc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.40
KMT2A Q03164 2/20 0.38
RAB9A P51151 2/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
GAA P10253 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA7 P43166 1/20 0.38
CA14 Q9ULX7 1/20 0.38
AKT1 P31749 2/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28699696 0.83 PDK1 (0.42) CA12CA1CA7CA14AKT1
SCHEMBL28699685 0.80 AKT1 (0.38) KCNN4KMT2ARAB9AMEN1NPC1
SCHEMBL28715025 0.79 MAPT (0.38) KCNN4KMT2ARAB9AMEN1NPC1
SCHEMBL28708777 0.79 AKT1 (0.40) KCNN4KMT2ARAB9AMEN1NPC1
SCHEMBL4367466 0.74 GPR119 (0.40) KMT2AMEN1L3MBTL1ATM
SCHEMBL23929822 0.73 GAA (0.44) KCNN4KMT2ARAB9AMEN1NPC1
SCHEMBL25866708 0.71 MEN1 (0.40) KMT2ARAB9AMEN1AKT1L3MBTL1
SCHEMBL14697845 0.71 NFKB1 (0.40) KMT2ARAB9AMEN1NPC1AKT1
SCHEMBL7659114 0.71 MTOR (0.50) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL775002 0.68 NAMPT (0.56) KMT2ARAB9AMEN1NPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114195676-B Biarylhydrazine compound and adduct thereof and application of compound in preparation of antitumor drugs 广州药本君安医药科技股份有限公司 2022-08-05 CN disclosed
CN-114195676-A Biarylhydrazine compound and adduct thereof and application of compound in preparation of antitumor drugs 广州药本君安医药科技股份有限公司 2022-03-18 CN disclosed